IL-6: The Link Between Inflammation, Immunity and Breast Cancer
- PMID: 35924148
- PMCID: PMC9341216
- DOI: 10.3389/fonc.2022.903800
IL-6: The Link Between Inflammation, Immunity and Breast Cancer
Abstract
Breast cancer is one of the leading causes of mortality in females. Over the past decades, intensive efforts have been made to uncover the pathogenesis of breast cancer. Interleukin-6 (IL-6) is a pleiotropic factor which has a vital role in host defense immunity and acute stress. Moreover, a wide range of studies have identified the physiological and pathological roles of IL-6 in inflammation, immune and cancer. Recently, several IL-6 signaling pathway-targeted monoclonal antibodies have been developed for cancer and immune therapy. Combination of IL-6 inhibitory antibody with other pathways blockage drugs have demonstrated promising outcome in both preclinical and clinical trials. This review focuses on emerging studies on the strong linkages of IL-6/IL-6R mediated regulation of inflammation and immunity in cancer, especially in breast cancer.
Keywords: breast cancer; immune; inflammation; interleukin-6; target therapy.
Copyright © 2022 Chen, Wei, Yang, Huang, Chen, Zeng and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.Pharmacol Ther. 2014 Feb;141(2):125-39. doi: 10.1016/j.pharmthera.2013.09.004. Epub 2013 Sep 27. Pharmacol Ther. 2014. PMID: 24076269 Review.
-
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer.Oncotarget. 2016 Mar 29;7(13):15460-73. doi: 10.18632/oncotarget.7102. Oncotarget. 2016. PMID: 26840088 Free PMC article. Review.
-
Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.Crit Care Med. 2003 May;31(5):1495-501. doi: 10.1097/01.CCM.0000065725.80882.BD. Crit Care Med. 2003. PMID: 12771624
-
TLRs: linking inflammation and breast cancer.Cell Signal. 2014 Nov;26(11):2350-7. doi: 10.1016/j.cellsig.2014.07.035. Epub 2014 Aug 3. Cell Signal. 2014. PMID: 25093807 Review.
-
Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.Transplantation. 2017 Jan;101(1):32-44. doi: 10.1097/TP.0000000000001452. Transplantation. 2017. PMID: 27547870 Review.
Cited by
-
Migratory Tumor Cells Cooperate with Cancer Associated Fibroblasts in Hormone Receptor-Positive and HER2-Negative Breast Cancer.Int J Mol Sci. 2024 May 28;25(11):5876. doi: 10.3390/ijms25115876. Int J Mol Sci. 2024. PMID: 38892065 Free PMC article.
-
Cracking the Codes behind Cancer Cells' Immune Evasion.Int J Mol Sci. 2024 Aug 15;25(16):8899. doi: 10.3390/ijms25168899. Int J Mol Sci. 2024. PMID: 39201585 Free PMC article. Review.
-
Phytochemical Composition and Antioxidant and Anti-Inflammatory Activities of Humboldtia sanjappae Sasidh. & Sujanapal, an Endemic Medicinal Plant to the Western Ghats.Molecules. 2023 Sep 29;28(19):6875. doi: 10.3390/molecules28196875. Molecules. 2023. PMID: 37836717 Free PMC article.
-
Special status of iron transfer proteins in the serum of breast cancer patients.Discov Oncol. 2025 May 31;16(1):972. doi: 10.1007/s12672-025-02799-3. Discov Oncol. 2025. PMID: 40450119 Free PMC article.
-
Solid stress compression enhances breast cancer cell migration through the upregulation of Interleukin-6.Front Cell Dev Biol. 2025 Apr 30;13:1541953. doi: 10.3389/fcell.2025.1541953. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40371393 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous